Journal article icon

Journal article

Variation in antiviral immunity and inflammation pathways precedes HIV-1 infection in a high-risk African cohort

Abstract:

Background

Susceptibility to human immunodeficiency virus type 1 (HIV-1) infection varies between individuals, but the biological determinants of acquisition risk remain poorly defined.

Methods

We conducted a case-control study nested within a high-risk cohort in Kenya. We compared the plasma extracellular RNA collected before HIV-1 acquisition with matched uninfected controls to identify immunological processes linked to infection risk.

Results

Individuals who later acquired HIV-1 exhibited upregulation of immune processes that facilitate viral infection, including T cell suppression, type II interferon and Th2 immune responses. In contrast, processes associated with antiviral defence and tissue repair, such as neutrophil and natural killer cell responses, type I interferon responses, wound healing, and angiogenesis, were downregulated.

Conclusion

These findings highlight dampened antiviral immunity prior to exposure as a correlate of increased risk for subsequent HIV-1 acquisition.

Trial numbers

Not applicable.

Funding

This work was supported by a Wellcome Trust Award (209289/Z/17/Z) and the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) through the DELTAS Africa programme [Del-22-007], supported by the Science for Africa Foundation, Wellcome Trust, the UK Foreign, Commonwealth & Development Office, and the European Union. Additional support was provided by the Bill & Melinda Gates Foundation, Gilead Sciences Inc., Aidsfonds, and the Ragon Institute of Mass General, MIT, and Harvard. The cohort study was supported by PEPFAR through USAID. The views expressed are those of the authors.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1172/jci195172

Authors

More by this author
Role:
Author
ORCID:
0000-0003-1961-3205
More by this author
Role:
Author
ORCID:
0000-0001-5296-4264
More by this author
Role:
Author
ORCID:
0000-0003-2876-3811


Publisher:
American Society for Clinical Investigation
Journal:
The Journal of Clinical Investigation More from this journal
Pages:
e195172
Publication date:
2026-02-12
DOI:
EISSN:
1558-8238
ISSN:
0021-9738


Language:
English
Keywords:
Pubs id:
2388024
Local pid:
pubs:2388024
Source identifiers:
W7128694942
Deposit date:
2026-03-12
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP